Q1 FY2025 Earnings
Financial report interval: 2024.03.30 - 2024.06.30
Overview: Nascent Biotech, Inc.(NBIO) the EBIT is -375.66 K (+26.62%);the EPS is -0.0022 (+42.72%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B26.62%
----
----
EPS
-0.002242.72%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf